Jahanshir, Mojgan
Nobahar, Monir
Ghorbani, Raheb
Malek, Farhad
Article History
Received: 7 November 2022
Accepted: 19 March 2023
First Online: 24 March 2023
Declarations
:
: We adhered to the ethical considerations by obtaining a license from the Semnan Ethics Committee (IR.SEMUMS.REC.1399.184), on 22.09.2020, the Iran Clinical Trial Registration Center IRCT20110427006318N13, and the vice-chancellor for research at Semnan University of Medical Sciences, explaining the research objectives to the participants and obtaining their informed consent to participate in the research, ensuring them of the voluntary participation in the study and the confidentiality terms. In addition, we appreciated the cooperation of the subjects and the authorities for their cooperation with the study.
: The authors declare no competing interests.
Free to read: This content has been made available to all.